148 related articles for article (PubMed ID: 26828283)
1. Recent achievements in colorectal cancer diagnostic and therapy by the use of nanoparticles.
Bartoş A; Bartoş D; Szabo B; Breazu C; Opincariu I; Mironiuc A; Iancu C
Drug Metab Rev; 2016; 48(1):27-46. PubMed ID: 26828283
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. Last Advances in Nanocarriers-Based Drug Delivery Systems for Colorectal Cancer.
Rama AR; Jimenez-Lopez J; Cabeza L; Jimenez-Luna C; Leiva MC; Perazzoli G; Hernandez R; Zafra I; Ortiz R; Melguizo C; Prados J
Curr Drug Deliv; 2016; 13(6):830-8. PubMed ID: 26634791
[TBL] [Abstract][Full Text] [Related]
4. Colorectal Cancer Management by Herbal Drug-Based Nanocarriers: An Overview.
Kulwal V; Baxi K; Sawarkar SP; Bhatt LK
Crit Rev Ther Drug Carrier Syst; 2020; 37(1):65-104. PubMed ID: 32450014
[TBL] [Abstract][Full Text] [Related]
5. Engineered nanoparticles for imaging and drug delivery in colorectal cancer.
Pavitra E; Dariya B; Srivani G; Kang SM; Alam A; Sudhir PR; Kamal MA; Raju GSR; Han YK; Lakkakula BVKS; Nagaraju GP; Huh YS
Semin Cancer Biol; 2021 Feb; 69():293-306. PubMed ID: 31260733
[TBL] [Abstract][Full Text] [Related]
6. Targeted nanoparticles for colorectal cancer.
Cisterna BA; Kamaly N; Choi WI; Tavakkoli A; Farokhzad OC; Vilos C
Nanomedicine (Lond); 2016 Sep; 11(18):2443-56. PubMed ID: 27529192
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticles for Colorectal Cancer Targeted Drug Delivery and MR Imaging: Current Situation and Perspectives.
Dong Z; Cui MY; Peng Z; Li Y; Wang X; Fang Z; Jiang M; Xu L; Luo Y; Li ZP; Feng ST
Curr Cancer Drug Targets; 2016; 16(6):536-50. PubMed ID: 26632434
[TBL] [Abstract][Full Text] [Related]
8. Nanomedicine for targeted cancer therapy: towards the overcoming of drug resistance.
Shapira A; Livney YD; Broxterman HJ; Assaraf YG
Drug Resist Updat; 2011 Jun; 14(3):150-63. PubMed ID: 21330184
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle therapeutics for prostate cancer treatment.
Sanna V; Sechi M
Nanomedicine; 2012 Sep; 8 Suppl 1():S31-6. PubMed ID: 22640911
[TBL] [Abstract][Full Text] [Related]
10. Role of integrated cancer nanomedicine in overcoming drug resistance.
Iyer AK; Singh A; Ganta S; Amiji MM
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
[TBL] [Abstract][Full Text] [Related]
11. Engineered nanoparticles for drug delivery in cancer therapy.
Sun T; Zhang YS; Pang B; Hyun DC; Yang M; Xia Y
Angew Chem Int Ed Engl; 2014 Nov; 53(46):12320-64. PubMed ID: 25294565
[TBL] [Abstract][Full Text] [Related]
12. Application of nanotechnology in the treatment and diagnosis of gastrointestinal cancers: review of recent patents.
Prados J; Melguizo C; Perazzoli G; Cabeza L; Carrasco E; Oliver J; Jiménez-Luna C; Leiva MC; Ortiz R; Álvarez PJ; Aranega A
Recent Pat Anticancer Drug Discov; 2014 Jan; 9(1):21-34. PubMed ID: 23676104
[TBL] [Abstract][Full Text] [Related]
13. Getting into the colon: approaches to target colorectal cancer.
Patel MM
Expert Opin Drug Deliv; 2014 Sep; 11(9):1343-50. PubMed ID: 24898947
[TBL] [Abstract][Full Text] [Related]
14. Colon cancer therapy: recent developments in nanomedicine to improve the efficacy of conventional chemotherapeutic drugs.
Prados J; Melguizo C; Ortiz R; Perazzoli G; Cabeza L; Alvarez PJ; Rodriguez-Serrano F; Aranega A
Anticancer Agents Med Chem; 2013 Oct; 13(8):1204-16. PubMed ID: 23574385
[TBL] [Abstract][Full Text] [Related]
15. Nanoparticles: Attractive tools to treat colorectal cancer.
Younis NK; Roumieh R; Bassil EP; Ghoubaira JA; Kobeissy F; Eid AH
Semin Cancer Biol; 2022 Nov; 86(Pt 2):1-13. PubMed ID: 36028154
[TBL] [Abstract][Full Text] [Related]
16. Co-delivery strategies based on multifunctional nanocarriers for cancer therapy.
Chen H; Zhao Y; Wang H; Nie G; Nan K
Curr Drug Metab; 2012 Oct; 13(8):1087-96. PubMed ID: 22380013
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions.
Anchordoquy TJ; Barenholz Y; Boraschi D; Chorny M; Decuzzi P; Dobrovolskaia MA; Farhangrazi ZS; Farrell D; Gabizon A; Ghandehari H; Godin B; La-Beck NM; Ljubimova J; Moghimi SM; Pagliaro L; Park JH; Peer D; Ruoslahti E; Serkova NJ; Simberg D
ACS Nano; 2017 Jan; 11(1):12-18. PubMed ID: 28068099
[TBL] [Abstract][Full Text] [Related]
18. Advances in combination therapies based on nanoparticles for efficacious cancer treatment: an analytical report.
Mignani S; Bryszewska M; Klajnert-Maculewicz B; Zablocka M; Majoral JP
Biomacromolecules; 2015 Jan; 16(1):1-27. PubMed ID: 25426779
[TBL] [Abstract][Full Text] [Related]
19. An update on nanoparticle-based contrast agents in medical imaging.
Naseri N; Ajorlou E; Asghari F; Pilehvar-Soltanahmadi Y
Artif Cells Nanomed Biotechnol; 2018 Sep; 46(6):1111-1121. PubMed ID: 28933183
[TBL] [Abstract][Full Text] [Related]
20. Gold nanoparticles: emerging paradigm for targeted drug delivery system.
Kumar A; Zhang X; Liang XJ
Biotechnol Adv; 2013; 31(5):593-606. PubMed ID: 23111203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
